Our data suggest that increased SAE1/UBA2-mediated SUMOylation may contribute to abnormal glycolysis and pathogenic behaviors of RA FLSs by targeting PKM2-mediated STAT5A. Here, STAT5A is linked to rheumatoid arthritis.